Sana Biotechnology, Inc. announced effective April 18, 2024, Douglas Williams, Ph.D. resigned from his position as Executive Vice President and President, Research and Development of the company. Dr. Williams resigned voluntarily for personal reasons and not as a result of any disagreement with the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.56 USD | +0.80% | -27.59% | +85.29% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+85.29% | 1.67B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- SANA Stock
- News Sana Biotechnology, Inc.
- Sana Biotechnology, Inc. Announces Resignation of Douglas Williams as Executive Vice President and President, Research and Development